Lawrence Livermore National Laboratory Chronic Beryllium Disease Prevention Program Effectiveness Review [HIAR-LLNL-2011-03-25]
The Lawrence Livermore National Laboratory (LLNL) and the Livermore Site Office (LSO) chartered a team to conduct an effectiveness review of the issues identified with the LLNL Chronic Beryllium Disease Prevention Program (CBDPP). The team included members and observers from LLNL, LSO, the National Nuclear Security Administration (NNSA), and the Office of Health, Safety and Security (HSS).
The team’s final report documents the results of the effectiveness review and the actions taken by LLNL to resolve and prevent recurrence of 44 issues identified in 9 Department of Energy (DOE) Noncompliance Tracking System reports, the 2008 NNSA independent review, and the HSS Office of Enforcement Consent Order WCO-2010-01. The HSS member assessed issues related to the sections of 10 Code of Federal Regulations 850 concerning medical surveillance and medical removal.